Long Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin Deficiency
Clinical trial NCT02796937 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT02796937
- Sponsor
- Grifols Therapeutics LLC
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2028-09-01
- Enrollment
- 290
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.